Nordic Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of cycles of rituximab with cyclophosphamide, doxorubicin, vincristine and prednisone (Maxi-CHOP), alternating with rituximab with high-dose (HD) cytarabine that can be used in the treatment of mantle cell lymphoma (MCL).

**Synonyms:** - Maxi-R-CHOP/R-HiDAC - Nordic - R-MaxiCHOP Plus R-HDAraC - Rituximab Plus Cyclophosphamide/Hydroxydaunorubicin/Oncovin/Prednisone and R-HD-Ara-C - Rituximab Plus Cyclophosphamide/Vincristine/Doxorubicin/Prednisone Alternating with Rituximab Plus High-Dose Cytarabine - Rituximab Plus Maxi-CHOP Alternating with Rituximab Plus HD Ara-C - Rituximab Plus Maxi-CHOP Alternating with Rituximab Plus High-Dose Cytarabine - Rituximab with Alternating Cycles of Maxi-CHOP and High-dose Cytarabine - Rituximab/Maxi-CHOP Alternating with Rituximab/High-Dose Cytarabine - maxi-R-CHOP/R-HiDAC - maxi-R-CHOP/R-HiDAC (rituximab-abbs) - maxi-R-CHOP/R-HiDAC (rituximab-arrx) - maxi-R-CHOP/R-HiDAC (rituximab-blit) - maxi-R-CHOP/R-HiDAC (rituximab-pvvr) - maxi-R-CHOP/R-HiDAC (rituximab-rite) - maxi-R-CHOP/R-HiDAC (rituximab-rixa) - maxi-R-CHOP/R-HiDAC (rituximab-rixi)